People

Sekhar Surapaneni

Nimbus Therapeutics vice president of drug metabolism, pharmacokinetics and clinical pharmacology, joining in 2024; previously led nonclinical disposition and bioanalysis at Bristol Myers Squibb and worked at Celgene, Amgen and Abbott.